Trials / Completed
CompletedNCT05915546
The Effect of Food on the Pharmacokinetics (PK) of Emraclidine in Healthy Adult Participants
A Phase 1, Open-label Trial to Evaluate the Effect of Food on the Pharmacokinetics of Emraclidine in Healthy Adult Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Cerevel Therapeutics, LLC · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The primary purpose of this study is to evaluate the effect of food (a high-fat meal) on the pharmacokinetics of emraclidine and metabolite CV-0000364 following single oral dose administration in healthy adult participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Emraclidine | Tablets |
Timeline
- Start date
- 2023-06-08
- Primary completion
- 2023-07-26
- Completion
- 2023-07-26
- First posted
- 2023-06-23
- Last updated
- 2023-11-24
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05915546. Inclusion in this directory is not an endorsement.